Parents of children with chronic lung conditions concerned with safety and side effects of COVID-19 vaccine

With the emergence of different SARS-CoV-2 variants of concern including the more transmissible Delta variant, children are more likely to become infected with COVID-19 than with previous variants. Although in most countries children are yet not vaccinated against COVID-19, many high-income countries including Australia have started vaccinating children aged 12 years and above. It is likely that by end of 2021 or early 2022, children as young as 5 years of age may be eligible for the COVID-19 vaccine.

Vaccinating children against COVID-19 will help protect against severe disease as well as help reduce community transmission. Children with chronic lung conditions are a priority group for vaccination against other respiratory infections including influenza and pneumococcal disease, as respiratory infections can be severe in these chidlren and lead to exacerbation of underlying lung condition.

 A survey recently conducted by researchers from the Discipline of Paediatrics at UNSW Medicine & Health, of parents and carers with children that suffer from chronic lung conditions found that while there was consensus among them about the severity of COVID-19, more than 80 per cent of the parents were willing to have their child vaccinated against COVID-19. However, safety and side effects of the vaccine were some of the major reasons reported for not wanting their child to be vaccinated against COVID-19.

More than 90 per cent of the parents and carers said they would have their child vaccinated if recommended by the child’s paediatrician. Additionally, 80 per cent of parents and carers said they would vaccinate their child if recommended by their GP.  The preferred locations for vaccination were the GP clinics or the hospital.

Paediatric respiratory epidemiologist Dr Nusrat Homaira, the lead author of the study that was conducted at the Sydney Children’s Hospital at Randwick said, “We know health care workers play an important role in promoting vaccine uptake. Children with chronic lung conditions is a unique group as they require ongoing follow-up visits with their GPs and paediatricians for their chronic conditions. GPs and paediatricians can leverage scheduled follow-up visits to promote COVID-19 vaccines and explain the benefits and rare side effects of the vaccine.”

###

The full study can be viewed here https://doi.org/10.1002/hsr2.410

For more information contact

Dr Nusrat Homaira